CI
40
-5
WFC
65
-3
QCOM
51
-5
UPS
55
4
XYL
54
-2
WM
65
-3
LYB
39
2
NDAQ
52
2
GME
57
-3
SJM
24
-7
AXP
70
6
DTE
49
2
BXP
52
-3
NKE
36
-3
ALLE
37
-4
EA
57
-2
MMM
35
-3
HUM
41
-2
RHI
57
-2
ADI
57
-3
CI
40
-5
WFC
65
-3
QCOM
51
-5
UPS
55
4
XYL
54
-2
WM
65
-3
LYB
39
2
NDAQ
52
2
GME
57
-3
SJM
24
-7
AXP
70
6
DTE
49
2
BXP
52
-3
NKE
36
-3
ALLE
37
-4
EA
57
-2
MMM
35
-3
HUM
41
-2
RHI
57
-2
ADI
57
-3
Financhill
Back

Vicapsys Life Sciences 10K Form

Buy
77

VICP
Vicapsys Life Sciences

Last Price:
7.0000
Seasonality Move:
-1.07%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VICP News And Ratings

See the #1 stock for the next 7 days that we like better than VICP

VICP Financial Statistics

Sales & Book Value

Annual Sales: $7.78M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $-0.04
Price / Book: 0

Profitability

EPS (TTM): -0.03380
Net Income (TTM): $-1.08M
Gross Margin: $544.52K
Return on Equity: 0%
Return on Assets: 0%

Vicapsys Life Sciences Earnings Forecast

Key Vicapsys Life Sciences Financial Ratios

  • The Gross Profit Margin over the past 2 years for VICP is 6.99%.
  • The Selling, General & Administrative Expenses for VICP have been equal to 23.77% of Gross Profit Margin.
  • The Interest Expense is -1.69% of Operating Income.
  • Per Share Earnings over the last 7 years have been positive in 4 years.

Vicapsys Life Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: VICP
Website: vicapsys.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

VICP Technical Analysis vs Fundamental Analysis

Buy
77
Vicapsys Life Sciences (VICP) is a Buy

Is Vicapsys Life Sciences a Buy or a Sell?